The U.S. cannabis industry added new states, new rules, and plenty of political momentum over the past few years - but it hasn't added many new businesses. Active cannabis business licenses dropped 1% in the first quarter of 2026 to 36,169, according to CRB Monitor, continuing a slide that now spans seven consecutive quarters and has erased 9% of licensed operators from the national count over two years. The question operators, investors, and license applicants need to answer honestly: is this a market in correction, or a market in contraction?

Fewer Licenses, Fewer Entrants - and a Shrinking Pipeline

Approved and pending licenses fell 4% in Q1 2026 to 4,175 - down 18% from the same period last year. That's not a rounding error. It reflects a meaningful slowdown in the pipeline of operators actually moving toward active status. CRB Monitor founder and CEO Steven Kemmerling described it plainly: "The decline extends a nearly unbroken three-year decline in licensed U.S. operators first evidenced in the fourth quarter of 2022."

The picture is messier than the headline number suggests, though. Pre-licensing activity - applications from businesses that haven't yet cleared any formal approval hurdle - ticked up 4% to 5,352. That signals continued interest in entry. But most of that activity is concentrated in two states: New York and Texas. And interest in entering a market is a very different thing from actually operating in one.

For wholesalers, software vendors, real estate investors, and payment providers who read new application volume as a leading indicator of future customer growth, the math here deserves scrutiny. Applications don't generate revenue. Licensed, operating dispensaries do.

New York's Backlog Is Distorting Every National Metric

New York alone accounts for more than 85% of pending cannabis applications in the United States - 4,522 applications under active review as of Q1 2026. During the quarter, regulators processed just 46 of them. That's 1% of the backlog cleared in three months.

Here's what that means in practice: the national licensing data is partly an artifact of one state's administrative gridlock. New York's application volume inflates pre-licensing counts, makes the pipeline appear more active than it is, and sets a ceiling on measurable growth that the market can't break through until the backlog actually clears. Operators waiting on New York approval are in limbo - capital deployed, leases often signed, build-outs sometimes underway - while the regulatory queue inches forward.

Vertical integration is one area where New York's influence is expected to grow. The state ended Q1 with 352 active vertically integrated operators and more than 800 vertical license applications pending review - likely pushing it toward the top tier of states by vertical operator count. New York's microbusiness license category is driving much of that interest, with applications for new vertical licenses up 16% nationally to nearly 1,000 permits. Vertically integrated operators - those handling cultivation, processing, and retail under a single license structure - have operational flexibility that single-tier licensees lack, but they also carry significantly higher compliance overhead across the full seed-to-sale chain.

Mature Markets Are Still Pulling Back

The contraction is most visible in states that opened early and grew fast. Michigan lost more than 300 licensed businesses in Q1 - an 8% decline - ending March with 3,719 active operators, down 10% from its peak in fall 2024. California shed another 154 licenses. Oklahoma dropped 5%, extending a two-year decline that has cut its licensed operator count nearly in half. New Mexico also lost more than 50 licenses during the quarter.

Oklahoma's situation is worth separating from the others. State officials have been actively denying existing licensees - enforcement and deliberate license attrition are driving the decline, not just market economics. Even so, Oklahoma still holds more active cannabis businesses than every state except California. The sheer number of operators that flooded into Oklahoma during its early, low-barrier licensing period created a market structure that regulators and the market alike have spent years unwinding.

For California and Michigan, the pressures are more familiar: high excise tax burdens, persistent illicit market competition, wholesale price compression, and thin margins that make small or single-location operators increasingly difficult to sustain. When a dispensary closes in a mature market, it often reflects a calculation that the economics of compliance - lab testing, compliant packaging, METRC reporting, local fees, state licensing costs - no longer pencil out against what the market will bear on price. Consolidation through acquisition or simple attrition tends to follow.

What's left behind in mature markets is a leaner, more professionalized operator base. That sounds like progress - and structurally, it may be - but it also means fewer points of sale, less wholesale demand, and tighter margins for everyone upstream in the supply chain.

Canada Offers a Different Model: Steady, Not Growing

Canada's licensed cannabis market barely moved in Q1 2026. The total count slid by five businesses to 5,807 - and no individual license category shifted more than 2% in either direction. Canada has shed just 7% of its active licenses over two years, a fraction of the U.S. rate of decline.

Kemmerling characterized it directly: "Licensed operators in the Canadian cannabis market have exhibited a degree of stability unknown in U.S. state markets, and the first quarter of 2026 was no different." New applications and approvals are rare. Canada isn't growing; it has settled.

That stability has its own costs - limited new market entry, restrained competition, and a ceiling on innovation from new operators - but for businesses already licensed and operating in Canada, the regulatory environment is at least predictable. Predictability has real value in an industry where compliance timelines, packaging rules, and licensing conditions can shift with little notice.

The contrast between the two countries reflects something structural, not cyclical. Canada built a federal licensing framework from the start, with consistent national rules. The U.S. market is a patchwork of 50 separate regulatory environments, each with its own license types, caps, application processes, social equity requirements, and enforcement postures. That complexity is partly why U.S. data is so hard to read cleanly - and why a single state's administrative backlog can distort a national dataset.

What the numbers collectively suggest is this: the U.S. cannabis industry has moved out of its expansion phase without arriving at stability. The sharp declines may be leveling off, but "leveling off" is not the same as growth. As Kemmerling put it, "overall trends in new licensing activity suggest sluggish store growth in aggregate for cannabis retailers going forward." For any business whose model depends on a growing number of dispensary doors to sell through, that's the sentence that matters most.